BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17454197)

  • 1. Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma.
    Di Mario A; Garzia M; d'Alò F; Rumi C; Massini G; Bellesi S; Zini G
    Hematology; 2007 Apr; 12(2):155-7. PubMed ID: 17454197
    [No Abstract]   [Full Text] [Related]  

  • 2. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
    Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C
    Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
    Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasmacytoid dendritic cell tumor].
    Pérez-Crespo M; Moragón M; Onrubia J; Sevila A; Alfonso R; Miralles J; Requena L
    Actas Dermosifiliogr; 2011 Apr; 102(3):229-31. PubMed ID: 21232729
    [No Abstract]   [Full Text] [Related]  

  • 5. CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
    Lan MX; Zhen ZX; Ming WH
    Leuk Lymphoma; 2009 Oct; 50(10):1715-7. PubMed ID: 19863343
    [No Abstract]   [Full Text] [Related]  

  • 6. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
    Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of blastic NK-cell lymphoma.
    Akasaka E; Mabuchi T; Umezawa Y; Iwashita K; Ohta Y; Matsuyama T; Ozawa A
    Int J Dermatol; 2007 Jul; 46(7):722-6. PubMed ID: 17614802
    [No Abstract]   [Full Text] [Related]  

  • 8. CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
    Hamadani M; Magro CM; Porcu P
    Br J Haematol; 2008 Jan; 140(2):122. PubMed ID: 17991297
    [No Abstract]   [Full Text] [Related]  

  • 9. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
    Ruggiero A; Maurizi P; Larocca LM; Arlotta A; Riccardi R
    Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
    Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
    J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A rare form of primary cutaneous lymphoma].
    Zehani A; Chelly I; Berjeb H; Vergier B; De Mascarel A; Kchir N
    Ann Pathol; 2014 Jun; 34(3):243-6. PubMed ID: 24950876
    [No Abstract]   [Full Text] [Related]  

  • 12. Adult T-cell lymphoma/leukemia presenting as pagetoid reticulosis of the palms and soles.
    Grubb B; Henderson DB; Pandya AG
    J Am Acad Dermatol; 2011 Nov; 65(5):1063-4. PubMed ID: 22000876
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
    Lin KW; Lee YS; Phipps C
    Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma.
    Galimberti S; Marasca R; Caracciolo F; Fazzi R; Papineschi F; Benedetti E; Guerrini F; Morabito F; Oliva E; Di Renzo N; Federico M; Petrini M; Torelli G;
    Bone Marrow Transplant; 2002 Apr; 29(7):581-7. PubMed ID: 11979307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous CD4/CD8-/- TCRαβ T-cell lymphoma.
    Fujimoto N; Kito K; Yoshida T; Tanaka T
    Acta Derm Venereol; 2015 Jan; 95(1):106-7. PubMed ID: 24890876
    [No Abstract]   [Full Text] [Related]  

  • 16. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
    Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M
    J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of localized lymphoma.
    Adli M; Sevinc A; Kalender ME
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948268
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
    Konopka L; Pawelski S
    J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of localized lymphoma.
    Tanvetyanon T
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15944432
    [No Abstract]   [Full Text] [Related]  

  • 20. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.